FiercePharmaAsia—Lilly China asset sale; Daiichi's bispecific I-O deal; Torrent 1M-bottle sartan recall
admin 26th April 2019 Uncategorised 0Eli Lilly sells legacy brands and a manufacturing facility in China to focus on new therapies. Daiichi Sankyo picks its first bispecific antibody developed under a deal with Zymeworks. Torrent Pharma recalls more than 1 million bottles of losartan. And more.
More: FiercePharmaAsia—Lilly China asset sale; Daiichi's bispecific I-O deal; Torrent 1M-bottle sartan recall
Source: fierce